secwatch.observer — SEC 8-K summary
======================================

Issuer:     Atara Biotherapeutics, Inc. (ATRA)
CIK:        0001604464
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001193125-25-139150
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Atara Biotherapeutics announces 2025 annual meeting results; all proposals approved
--------------------------------------------------------------------------------

- Elected directors: AnhCo Nguyen (2.71M for), Matthew Fust (2.58M for), Gregory Ciongoli (2.99M for).
- Advisory vote on executive compensation approved 2.98M for vs 43K against.
- Frequency of say-on-pay set to one year (3.00M votes for one year).
- Ratified Deloitte & Touche as auditor for FY2025 with 4.39M for, 69K against, 79K abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604464/000119312525139150/0001193125-25-139150-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604464/000119312525139150/d935254d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-139150

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer